SUMMARY Twenty-seven patients with vernal conjunctivitis who remained symptomatic following treatment with corticosteroid drops and/or Opticrom drops (sodium cromoglycate 2%, benzalkonium chloride 0.01%) were treated with aspirin. Aspirin produced marked improvement in all patients apart from three. The possible mechanism of the efficacy of aspirin in vernal conjunctivitis is discussed.
Vernal conjunctivitis is a severe perennial form of allergic conjunctivitis involving the conjunctiva and often also the cornea. The condition is found predominantly in children or young adults. The main symptoms are those of severe itching, photophobia, and the production of a tenacious, stringy, mucous discharge. The disease generally affects the upper tarsal conjunctiva with papillary hypertrophy and cobblestone appearance. In severe cases the limbal conjunctiva may also be affected, causing localised oedema and hyperaemia or fleshy isolated vegetations. Punctate keratitis and indolent corneal ulceration may also occur.
The topical application of corticosteroids may be of considerable benefit. But control is not complete in all cases, and its long term use can produce glaucoma. The efficacy of sodium cromoglycate 2% (Opticrom) remains controversial. ' Aspirin therapy in mastocytosis was found to be beneficial, and, since the pathophysiology of both mastocytosis and vernal conjunctivitis involves mast cell abnormalities, the use of aspirin in treating the latter was tried in three patients.4
We report here the effect of aspirin therapy on 27 patients with vernal conjunctivitis.
Material and methods
Twenty-seven patients aged 4-18 years were treated with aspirin; 24 were males and three were females. All the 27 patients had been treated prior to aspirin with steroid drops topically and 15 with Opticrom drops too; nevetheless they remained symptomatic. In three patients the disease was so severe that they received prednisone tablets. The patients had been under our follow-up before aspirin treatment for an average of 1-5 years, and the duration of the disease had lasted up to 4 years.
The patients were questioned for photophobia, lacrimation, and itching. On examination they were divided into cases of palpebral, limbal, and mixed type of vernal conjunctivitis, with special emphasis on superficial punctate keratopathy. Twenty-three patients complained of severe photophobia, 22 of itching, and 18 of lacrimation. On examination 14 patients presented with the palpebral type, three with the limbal type, and 10 with mixed vernal conjunctivitis. Twenty patients presented with superficial punctate keratopathy and two had corneal ulcers (nos. 5, 10) prior to aspirin therapy.
The dosage of aspirin in our patients varied between 0*5 g and 1-5 g daily, depending on the patient's age. During aspirin treatment cortisteroid as well as Opticrom drops were withheld. The duration of therapy for the acute inflammatory stage was six weeks, followed by gradual weaning from the drug, clinical findings permitting.
Results
The results are summarised in punctate keratopathy remained, and in three other mine and prostaglandin D2.6 Prostaglandin D2 is the patients limbal papillae were still visible. In this mast cells' most prevalent prostaglandin, and its role group of patients no adverse reaction to aspirin was in inflammation has been recently appreciated.7 observed.
In vernal conjunctivitis the percentage of degranulated mast cells is increased, probably signifying Discussion prostaglandin release.8 The process of degranulation is believed to be due to antigen induced bridging of The incidence of vernal conjunctivitis is particularly IgE molecules which are bound to specific receptors high in Israel, and apparently some of its features are on the mast cell surface. Aspirin acts by acetylating different from those in temperate zones.' The disease the active sites of cyclo-oxigenase, thus interrupting in this country seems to be less seasonal than has been the production of prostaglandin D2 from its precursor reported elsewhere. It has also been stressed that the arachidonic acid.9 Hence aspirin may block the incidence of other atopic disorders in children with production of the inflammation producing prostavernal conjunctivitis was only 11%, which is similar glandin in mast cells released in vernal conjunctivitis to the incidence of atopic disorders among other by an antigen-dependent mechanism. Indeed, children of the same age. This finding may explain application of arachidonic acid, the precursor of why only a selective group of children with vernal prostaglandin D2 produces conjunctival redness and conjunctivitis, namely those who present with other chemosis in rabbits."'' allergic conditions, react well to cromoglycate.
We have administered aspirin to 27 patients who, In spite of treatment with steroids and cromo-in spite of local steroid drops and/or opticrom, glycate our patients remained symptomatic. Mast cell remained symptomatic. After treatment with aspirin abnormalities characterise both vernal conjunctivitis the symptoms and signs improved in all but three and mastocytosis, a generalised disease of mast cell patients (nos. 12, 16, 27). Aspirin produced marked proliferation with increased serum levels of hista-improvement in the punctate keratopathy and limbal Efficacy ofantiprostaglandin therapy in vernal conjunctivitis infiltration in most patients. The cobblestones of the upper tarsus did not disappear but were smaller and less inflamed.
The limitation of this study is that the efficacy of acetylsalicylic acid treatment was not evaluated in a masked fashion. The gravity of the disease in this group, however, prevented us from applying a procedure using a placebo. We believe that the marked improvement in signs and symptoms of vernal conjunctivitis in most patients receiving aspirin only for extended periods of time, following the failure of corticosteroids and cromoglycate, strongly suggests the efficacy of this treatment beyond a placebo effect.
We conclude that aspirin is an additional therapeutic tool in the treatment of vernal conjunctivitis and can be tried as the only treatment in new cases of vernal conjunctivitis, in conjunction with tear drop substitutes to help prevent punctate keratopathy by lubricating the cornea. The clinician must, however, be alert to the possible side effects of aspirin, namely increased bleeding tendency, gastritis, and Reye's syndrome. It may also worsen the bronchial asthma which occasionally occurs in these allergic children.
